首页|期刊导航|中华中医药杂志|基于"肠-肾轴"理论探讨肾必宁颗粒对IgA肾病大鼠的抗炎机制

基于"肠-肾轴"理论探讨肾必宁颗粒对IgA肾病大鼠的抗炎机制OA

Exploration on the anti-inflammatory mechanism of Shenbining Granules on IgA nephropathy rats based on the theory of'gut-kidney axis'

中文摘要英文摘要

目的:基于"肠-肾轴"理论研究肾必宁颗粒对IgA肾病(IgAN)大鼠脾酪氨酸激酶(Syk)炎症信号通路及结肠病理的影响,探讨肾必宁颗粒治疗IgAN的机制.方法:将42只雄性SD大鼠随机分为对照组、模型组、泼尼松组(12.5 mg/kg)及肾必宁颗粒低(20.5 g/kg)、高(41.0 g/kg)剂量组.采用牛血清白蛋白(BSA)灌胃、四氯化碳(CCl4)和蓖麻油皮下注射及脂多糖(LPS)尾静脉注射的方法建立IgAN大鼠模型,于造模第4周开始各组给予相应剂量的药物,对照组和模型组给予等量蒸馏水灌胃.连续灌胃14周后留取大鼠血液、尿液、肾脏及结肠组织.生化检测各组大鼠24 h尿蛋白定量(24h-UTP)、尿红细胞计数(URBC),血清白蛋白(ALB)、谷丙转氨酶(ALT)、血肌酐(Scr)及尿素氮(BUN)水平;苏木素-伊红(HE)染色观察肾组织及结肠病理形态学变化;免疫荧光观察肾小球系膜区IgA沉积;ELISA法检测血清肿瘤坏死因子-α(TNF-α)、白细胞介素-1 β(IL-1 β)水平;Western Blot、Real-time PCR检测各组大鼠肾组织脾酪氨酸激酶(Syk)/胱天蛋白酶募集域蛋白9(CARD9)/核因子-κB(NF-κB)蛋白含量及其mRNA表达水平.结果:与对照组比较,模型组大鼠24h-UTP、URBC,血清ALT、Scr、BUN、TNF-α、IL-1 β,肾组织Syk、CARD9、NF-κB蛋白含量及其mRNA表达水平均显著升高(P<0.01),血清ALB显著降低(P<0.01),光镜下结肠及肾脏病理组织损伤明显,免疫荧光可见较强团块状IgA沉积;与模型组比较,各给药组大鼠24h-UTP、URBC,血清ALT、Scr、BUN、TNF-α、IL-1 β,肾组织Syk、CARD9、NF-κB蛋白含量及其mRNA表达水平均明显降低(P<0.05,P<0.01),血清ALB显著升高(P<0.01),光镜下结肠及肾脏病理组织损伤明显改善,免疫荧光可见IgA沉积减少.结论:肾必宁颗粒可通过调控Syk/CARD9/NF-κB炎症信号通路,抑制IgAN大鼠肠黏膜免疫炎症反应,改善结肠和肾脏病理损伤.

Objective:To study the effects of Shenbining Granules on the inflammatory signaling pathway of spleen tyrosine kinase(Syk)and colonic pathology in IgA nephropathy(IgAN)rats based on the theory of'gut-kidney axis',and to explore the mechanism of Shenbining Granules in treating IgAN.Methods:A total of 42 male SD rats were randomly divided into control group,model group,prednisone group(12.5 mg/kg)and Shenbining Granules low-dose(20.5 g/kg)and high-dose(41.0 g/kg)groups.The IgAN rat model was established by intragastric administration of bovine serum albumin(BSA),subcutaneous injection of carbon tetrachloride(CCl4)and castor oil,tail vein injection of lipopolysaccharide(LPS).Starting from the 4th week of modeling,each group was given the corresponding dose of drug intragastric administration,and the control group and model group were given the same amount of distilled water.After 14 weeks of continuous intragastric administration,blood,urine,kidney and colon tissues were collected.The levels of 24 h urinary protein(24 h-UTP),urine red blood cell count(URBC),serum albumin(ALB),alanine aminotransferase(ALT),serum creatinine(Scr)and blood urea nitrogen(BUN)were detected.Hematoxylin-eosin(HE)staining was used to observe the pathological changes of kidney tissue and colon.IgA deposition in mesangial region was observed by immunofluorescence.Serum tumor necrosis factor-α(TNF-α)and interleukin-1β(IL-1β)levels were detected by ELISA.Western Blot,Real-time PCR was used to detect the protein content and mRNA expression of spleen tyrosine kinase(Syk)/caspase recruitment domain protein 9(CARD9)/nuclear factor-κB(NF-κB)in spleen of each group.Results:Compared with control group,24 h-UTP,URBC,serum ALT,Scr,BUN,TNF-α,IL-1β,renal Syk,CARD9,NF-κB protein contents and mRNA expression levels of rats in model group were significantly increased(P<0.01),while serum ALB was significantly decreased(P<0.01).The pathological tissue damage of colon and kidney was obvious under light microscope,and strong clumpy IgA deposition was observed by immunofluorescence.Compared with model group,24 h-UTP,URBC,serum ALT,Scr,BUN,TNF-α,IL-1β,renal Syk,CARD9,NF-κB protein content and mRNA expression levels of rats in intervention groups were significantly decreased(P<0.05,P<0.01).Serum ALB was significantly increased(P<0.01).The pathological tissue injury of colon and kidney was obviously improved under light microscope.Immunofluorescence showed decreased IgA deposition.Conclusion:Shenbining Granules can inhibit the immune inflammatory response of intestinal mucosa in IgAN rats and improve the pathological injury of colon and kidney by regulating the Syk/CARD9/NF-κB inflammatory signaling pathway.

贾评评;宋纯东;宋丹;宋珂;王宁丽;龚学忠;任献青;翟文生;丁樱

河南中医药大学第一附属医院儿科医院,郑州 450000||河南中医药大学儿科医学院,郑州 450046河南中医药大学第一附属医院儿科医院,郑州 450000||河南中医药大学儿科医学院,郑州 450046河南中医药大学第一临床医学院,郑州 450046河南中医药大学儿科医学院,郑州 450046河南中医药大学第一附属医院儿科医院,郑州 450000上海中医药大学附属市中医医院,上海 200071河南中医药大学第一附属医院儿科医院,郑州 450000||河南中医药大学儿科医学院,郑州 450046河南中医药大学第一附属医院儿科医院,郑州 450000||河南中医药大学儿科医学院,郑州 450046河南中医药大学第一附属医院儿科医院,郑州 450000||河南中医药大学儿科医学院,郑州 450046

肾必宁IgA肾病肠-肾轴脾酪氨酸激酶/胱天蛋白酶募集域蛋白9/核因子-κB通路结肠病理

Shenbining GranulesIgA nephropathy(IgAN)Gut-kidney axisSyk/CARD9/NF-κB pathwayPathology of colon

《中华中医药杂志》 2026 (3)

918-924,7

国家自然科学基金面上项目(No.82074493),河南省中医药学科领军人才项目[No.豫卫中医函(2021)8号],河南省中医药科研专项(No.2025LHZX2180),河南省科技厅科技攻关项目(No.262102311230)

评论